Reaction
Pericardial Effusion Malignant reporting signals
As of the last recalculation, Pericardial Effusion Malignant appears in 172 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is OSIMERTINIB (PRR 40.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Osimertinib | 10 | 40.0 | 40.0 |
| Guselkumab | 6 | 21.0 | 21.0 |